Abstract
Abstract #1493875: Efficacy and Safety of Short-term Continuous Subcutaneous Native GLP-1 Infusion Versus Intensive Insulin (CSII) Treatment in Patients with Newly Diagnosed Type 2 diabetes
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
